AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENTAmended and Restated Exclusive License Agreement • August 18th, 2021 • PROCEPT BioRobotics Corp • Surgical & medical instruments & apparatus • California
This Amended and Restated Exclusive License Agreement (this “Agreement”) is effective as of September 13, 2019 (the “Effective Date”) by and between AquaBeam LLC, a California limited liability company having offices at 2995 Woodside Road, Suite 100, Woodside, California 94062 (“AquaBeam”), and PROCEPT BioRobotics Corporation, a California corporation having offices at 900 Island Dr #210, Redwood City, CA 94065 (“Procept”). AquaBeam and Procept may be referred to herein individually as a “Party” and collectively as the “Parties.”
AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENTAmended and Restated Exclusive License Agreement • August 5th, 2019 • Kura Sushi Usa, Inc. • Retail-eating places • California
THIS AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT (“Agreement”) is entered into on August 5, 2019 (the “Effective Date”) by and between Kura Sushi, Inc. (“Licensor”), a Japanese corporation having its registered address at 1-2-2 Fukasaka, Naka-ku, Sakai-shi, Osaka and Kura Sushi USA, Inc. (“Licensee”), a Delaware corporation having its principal place of business at 17932 Sky Park Circle, Suite H, Irvine, CA 92614 (collectively as the “Parties” and individually as a “Party”).
AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENTAmended and Restated Exclusive License Agreement • September 27th, 2019 • Theratechnologies Inc. • Pharmaceutical preparations • Quebec
This amended and restated exclusive license agreement (this “Agreement”) is made and entered into this 25th day of February, 2019 (the “Effective Date”).
Amended and Restated Exclusive License AgreementAmended and Restated Exclusive License Agreement • June 22nd, 2021 • Rani Therapeutics Holdings, Inc. • Pharmaceutical preparations • California
This exclusive license agreement (this “Agreement”) is made by and between InCube Labs, LLC (“InCube” or “Licensor”) a Delaware limited liability company having an address at 2051 Ringwood Ave., San Jose, CA 95131, and Rani Therapeutics, LLC (“Rani” or “Licensee”), a California limited liability company having an address at 2051 Ringwood Ave., San Jose, CA 95131. InCube and Rani may be referred to herein individually as a “Party” and collectively as the “Parties”.
AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENTAmended and Restated Exclusive License Agreement • September 9th, 2011 • Protea Biosciences Inc. • Blank checks • District of Columbia
This Amended and Restated Exclusive License Agreement (“Agreement”) is made as of February 22, 2010 (the “Effective Date”), by and between The George Washington University, a congressionally chartered not for profit corporation (“University”), located in the District of Columbia, and PROTEA BIOSCIENCES, INC., a for profit corporation (“Company”), having a place of business at 955 Hartman Run Road, Suite 210, Morgantown, WV 26507. University and Company may each be referred to herein individually as “Party” and collectively as the “Parties”.
AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENTAmended and Restated Exclusive License Agreement • September 14th, 2004 • Natural Alternatives International Inc • Medicinal chemicals & botanical products • California
This AMENDED AND RESTATED EXCLUSIVE LICENSING AGREEMENT (“Agreement”) is entered into effective as of February 5, 2003, between Natural Alternatives International, Inc., a Delaware corporation (“NAI”), with its principal offices at 1185 Linda Vista Drive, San Marcos, California 92069, and the Chopra Enterprises, LLC, a California limited liability company (“Chopra Enterprises”), Deepak Chopra, M.D., an individual (“Deepak Chopra”) and David Simon, M.D., an individual (“Simon”). Chopra Enterprises, Deepak Chopra and Simon are sometimes referred to collectively as “CCS.” The Parties to this Agreement are sometimes referred to collectively herein as the “Parties” or separately with NAI alone, and CCS collectively referred to as a “Party.”
AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENTAmended and Restated Exclusive License Agreement • April 16th, 2019 • Bone Biologics Corp • Orthopedic, prosthetic & surgical appliances & supplies • California
THIS AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) is made as of March 21, 2019, and effective as of March 15, 2006 (the “Effective Date”), and is entered into between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (“The Regents”), a California corporation having its corporate offices located at 1111 Franklin Street, Oakland, California 94607-5200, acting through its offices located at 10920 Wilshire Blvd, Suite 1200, Los Angeles, California, 90024-1406, and BONE BIOLOGICS CORPORATION (“Licensee”), a Delaware corporation having a principal place of business at 2 Burlington Woods Drive, Suite 100, Burlington, Massachusetts, 01803.
